We are live on ! Find out more
DKCM

Davidson Kempner Capital Management Portfolio holdings

AUM $7.33B
1-Year Est. Return 56.47%
This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+56.47%
3 Year Est. Return
+139.87%
5 Year Est. Return
+217.47%
10 Year Est. Return
+1,125.15%
AUM
$7.6B
AUM Growth
+$1.03B
Cap. Flow
-$1.01B
Cap. Flow %
-13.36%
Top 10 Hldgs %
44.16%
Holding
314
New
64
Increased
25
Reduced
25
Closed
50

Top Buys

Rank Stock Value
1
HES
Hess
HES
+$459M
2
CTLT
CATALENT, INC.
CTLT
+$115M
3
WRK
WestRock Company
WRK
+$95.6M
4
DG icon
Dollar General
DG
+$79.5M
5
ANSS
Ansys
ANSS
+$77.9M

Top Sells

Rank Stock Value
1
X
US Steel
X
+$342M
2
SMCI icon
Super Micro Computer
SMCI
+$110M
3
IMGN
Immunogen Inc
IMGN
+$96.5M
4
SPLK
Splunk Inc
SPLK
+$88.8M
5
PXD
Pioneer Natural Resource Co.
PXD
+$76.7M

Sector Composition

Rank Sector Weight
1 Energy 23.91%
2 Consumer Discretionary 16.44%
3 Technology 5.34%
4 Communication Services 4.8%
5 Consumer Staples 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CONXW
151
DELISTED
CONX Corp. Warrant
CONXW
$48.8K ﹤0.01%
325,000
– –
ML.WS
152
DELISTED
MoneyLion Inc. Warrants, each whole warrant exercisable 1/30th of a share of Class A common stock at an exercise price of $345.00 per whole share
ML.WS
$46.6K ﹤0.01%
517,389
– –
AONCW
153
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$36.3K ﹤0.01%
125,000
– –
FLDDW
154
Fold Holdings Warrant
FLDDW
$1.12M
$36.2K ﹤0.01%
425,000
– –
PROCW
155
DELISTED
Procaps Group, S.A. Warrants
PROCW
$36.1K ﹤0.01%
547,600
– –
BAERW icon
156
Bridger Aerospace Warrant
BAERW
$8.48M
$35.2K ﹤0.01%
195,399
– –
JWSM.WS
157
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$34.9K ﹤0.01%
162,498
– –
CVIIW
158
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$30K ﹤0.01%
100,000
– –
SOAR.WS
159
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$30K ﹤0.01%
200,000
– –
RVMDW icon
160
Revolution Medicines Inc Warrant
RVMDW
$127M
$28.5K ﹤0.01%
150,000
– –
ALUR.WS
161
DELISTED
Allurion Technologies Warrants
ALUR.WS
$24.7K ﹤0.01%
97,826
– –
APXIW
162
DELISTED
APx Acquisition Corp. I Warrant
APXIW
$22.5K ﹤0.01%
150,000
– –
VLN.WS
163
DELISTED
Valens Semiconductor Ltd Warrants
VLN.WS
$22.3K ﹤0.01%
350,000
– –
ZEOWW
164
Zeo Energy Corp Warrants
ZEOWW
$21K ﹤0.01%
200,000
– –
VSTEW
165
DELISTED
Vast Renewables Limited Warrants
VSTEW
$21K ﹤0.01%
300,000
– –
BYNOW
166
DELISTED
byNordic Acquisition Corporation Warrant
BYNOW
$18.7K ﹤0.01%
371,250
– –
LLAP.WS
167
DELISTED
Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
LLAP.WS
$18.6K ﹤0.01%
116,667
– –
BFAC.WS
168
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
$17.6K ﹤0.01%
500,000
– –
TVGNW icon
169
Tevogen Inc. Warrant
TVGNW
$976K
$17.5K ﹤0.01%
250,000
– –
MNTN.WS
170
DELISTED
Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50
MNTN.WS
$16.5K ﹤0.01%
87,500
– –
RDZNW icon
171
Roadzen Inc Warrants
RDZNW
$8.64M
$16.3K ﹤0.01%
175,000
– –
MCAAW
172
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
$15.8K ﹤0.01%
225,000
– –
OSI.WS
173
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
$15K ﹤0.01%
500,000
– –
CITEW
174
DELISTED
Cartica Acquisition Corp Warrant
CITEW
$14K ﹤0.01%
175,000
– –
RCFA.WS
175
DELISTED
RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RCFA.WS
$13.4K ﹤0.01%
250,000
– –
5 6
7
8 9

Similar funds

KWM
Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return

Davidson Kempner Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Davidson Kempner Capital Management held 314 positions worth $7.6B, up 16% from $6.57B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Davidson Kempner Capital Management withdrew a net $1.01B in Q1 2024, closing 50 positions and reducing 25 holdings. Its most notable exit was Immunogen Inc, an estimated $96.5M position sold in full.

By sector, the portfolio is most concentrated in Energy at 24% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Davidson Kempner Capital Management opened a new position in CATALENT, INC. worth $120M.

  • Davidson Kempner Capital Management's largest Q1 2024 buy was CATALENT, INC.: 2,123,393 shares worth $120M.
  • Davidson Kempner Capital Management added most to Hess in Q1 2024, an estimated $459M increase.
  • Davidson Kempner Capital Management's biggest Q1 2024 reduction was US Steel, cutting an estimated $342M.
  • Davidson Kempner Capital Management fully exited Immunogen Inc in Q1 2024, selling an estimated $96.5M.
  • Davidson Kempner Capital Management's ten largest holdings make up 44% of its $7.6B portfolio in Q1 2024.
  • Davidson Kempner Capital Management opened 64 new positions and closed 50 in Q1 2024.
  • Davidson Kempner Capital Management's portfolio value rose 16% quarter-over-quarter to $7.6B.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2024, filed 15 May 2024.